接受 TAVI 的主动脉瓣狭窄患者 PCI 策略的比较分析:系统回顾与网络元分析》。

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Parisa Fallahtafti, Hamidreza Soleimani, Pouya Ebrahimi, Amirhossein Ghaseminejad-Raeini, Elaheh Karimi, Amirhossein Shirinezhad, Mahshad Sabri, Mehdi Mehrani, Homa Taheri, Robert Siegel, Neeraj Shah, Michael Nanna, Diaa Hakim, Kaveh Hosseini
{"title":"接受 TAVI 的主动脉瓣狭窄患者 PCI 策略的比较分析:系统回顾与网络元分析》。","authors":"Parisa Fallahtafti,&nbsp;Hamidreza Soleimani,&nbsp;Pouya Ebrahimi,&nbsp;Amirhossein Ghaseminejad-Raeini,&nbsp;Elaheh Karimi,&nbsp;Amirhossein Shirinezhad,&nbsp;Mahshad Sabri,&nbsp;Mehdi Mehrani,&nbsp;Homa Taheri,&nbsp;Robert Siegel,&nbsp;Neeraj Shah,&nbsp;Michael Nanna,&nbsp;Diaa Hakim,&nbsp;Kaveh Hosseini","doi":"10.1002/clc.24324","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Transcatheter aortic valve implantation (TAVI) has been increasingly used in patients with severe aortic stenosis (AS). Since coronary artery disease (CAD) is common among these patients, it is crucial to choose the best method and timing of revascularization. This study aims to compare different timing strategies of percutaneous coronary intervention (PCI) in patients with severe AS undergoing TAVI to clarify whether PCI timing affects the patients' outcomes or not.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A frequentist network meta-analysis was conducted comparing three different revascularization strategies in patients with CAD undergoing TAVI. The 30-day all-cause mortality, in-hospital mortality, all-cause mortality at 1 year, 30-day rates of myocardial infarction (MI), stroke, and major bleeding, and the need for pacemaker implantation at 6 months were analyzed in this study.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Our meta-analysis revealed that PCI during TAVI had higher 30-day mortality (RR = 2.46, 95% CI = 1.40–4.32) and in-hospital mortality (RR = 1.70, 95% CI = [1.08–2.69]) compared to no PCI. Post-TAVI PCI was associated with higher 1-year mortality compared to other strategies. While no significant differences in major bleeding or stroke were observed, PCI during TAVI versus no PCI (RR = 3.63, 95% CI = 1.27–10.43) showed a higher rate of 30-day MI.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Our findings suggest that among patients with severe AS and CAD undergoing TAVI, PCI concomitantly with TAVI seems to be associated with worse 30-day outcomes compared with no PCI. PCI after TAVI demonstrated an increased risk of 1-year mortality compared to alternative strategies. Choosing a timing strategy should be individualized based on patient characteristics and procedural considerations.</p>\n </section>\n </div>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11272956/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparative Analysis of PCI Strategies in Aortic Stenosis Patients Undergoing TAVI: A Systematic Review and Network Meta-Analysis\",\"authors\":\"Parisa Fallahtafti,&nbsp;Hamidreza Soleimani,&nbsp;Pouya Ebrahimi,&nbsp;Amirhossein Ghaseminejad-Raeini,&nbsp;Elaheh Karimi,&nbsp;Amirhossein Shirinezhad,&nbsp;Mahshad Sabri,&nbsp;Mehdi Mehrani,&nbsp;Homa Taheri,&nbsp;Robert Siegel,&nbsp;Neeraj Shah,&nbsp;Michael Nanna,&nbsp;Diaa Hakim,&nbsp;Kaveh Hosseini\",\"doi\":\"10.1002/clc.24324\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Transcatheter aortic valve implantation (TAVI) has been increasingly used in patients with severe aortic stenosis (AS). Since coronary artery disease (CAD) is common among these patients, it is crucial to choose the best method and timing of revascularization. This study aims to compare different timing strategies of percutaneous coronary intervention (PCI) in patients with severe AS undergoing TAVI to clarify whether PCI timing affects the patients' outcomes or not.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>A frequentist network meta-analysis was conducted comparing three different revascularization strategies in patients with CAD undergoing TAVI. The 30-day all-cause mortality, in-hospital mortality, all-cause mortality at 1 year, 30-day rates of myocardial infarction (MI), stroke, and major bleeding, and the need for pacemaker implantation at 6 months were analyzed in this study.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Our meta-analysis revealed that PCI during TAVI had higher 30-day mortality (RR = 2.46, 95% CI = 1.40–4.32) and in-hospital mortality (RR = 1.70, 95% CI = [1.08–2.69]) compared to no PCI. Post-TAVI PCI was associated with higher 1-year mortality compared to other strategies. While no significant differences in major bleeding or stroke were observed, PCI during TAVI versus no PCI (RR = 3.63, 95% CI = 1.27–10.43) showed a higher rate of 30-day MI.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Our findings suggest that among patients with severe AS and CAD undergoing TAVI, PCI concomitantly with TAVI seems to be associated with worse 30-day outcomes compared with no PCI. PCI after TAVI demonstrated an increased risk of 1-year mortality compared to alternative strategies. Choosing a timing strategy should be individualized based on patient characteristics and procedural considerations.</p>\\n </section>\\n </div>\",\"PeriodicalId\":2,\"journal\":{\"name\":\"ACS Applied Bio Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-07-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11272956/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Bio Materials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/clc.24324\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/clc.24324","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

摘要

背景:经导管主动脉瓣植入术(TAVI)已越来越多地用于重度主动脉瓣狭窄(AS)患者。由于冠状动脉疾病(CAD)在这些患者中很常见,因此选择最佳的血管再通方法和时机至关重要。本研究旨在比较接受TAVI的重度主动脉瓣狭窄患者经皮冠状动脉介入治疗(PCI)的不同时机策略,以明确PCI时机是否会影响患者的预后:方法: 对接受 TAVI 的 CAD 患者进行了频数网络荟萃分析,比较了三种不同的血管重建策略。该研究分析了 30 天全因死亡率、院内死亡率、1 年全因死亡率、30 天心肌梗死(MI)、中风和大出血发生率以及 6 个月时起搏器植入需求:我们的荟萃分析显示,与不进行 PCI 相比,TAVI 期间进行 PCI 的 30 天死亡率(RR = 2.46,95% CI = 1.40-4.32)和院内死亡率(RR = 1.70,95% CI = [1.08-2.69])更高。与其他策略相比,TAVI 术后 PCI 与较高的 1 年死亡率相关。虽然在大出血或中风方面未观察到明显差异,但TAVI期间进行PCI与不进行PCI相比(RR = 3.63,95% CI = 1.27-10.43),30天心肌梗死发生率更高:我们的研究结果表明,在接受 TAVI 的重度 AS 和 CAD 患者中,与不进行 PCI 相比,在 TAVI 期间同时进行 PCI 似乎与更差的 30 天预后相关。与其他策略相比,TAVI 术后进行 PCI 会增加 1 年死亡率风险。应根据患者特征和手术考虑因素选择个体化的时机策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Comparative Analysis of PCI Strategies in Aortic Stenosis Patients Undergoing TAVI: A Systematic Review and Network Meta-Analysis

Comparative Analysis of PCI Strategies in Aortic Stenosis Patients Undergoing TAVI: A Systematic Review and Network Meta-Analysis

Background

Transcatheter aortic valve implantation (TAVI) has been increasingly used in patients with severe aortic stenosis (AS). Since coronary artery disease (CAD) is common among these patients, it is crucial to choose the best method and timing of revascularization. This study aims to compare different timing strategies of percutaneous coronary intervention (PCI) in patients with severe AS undergoing TAVI to clarify whether PCI timing affects the patients' outcomes or not.

Methods

A frequentist network meta-analysis was conducted comparing three different revascularization strategies in patients with CAD undergoing TAVI. The 30-day all-cause mortality, in-hospital mortality, all-cause mortality at 1 year, 30-day rates of myocardial infarction (MI), stroke, and major bleeding, and the need for pacemaker implantation at 6 months were analyzed in this study.

Results

Our meta-analysis revealed that PCI during TAVI had higher 30-day mortality (RR = 2.46, 95% CI = 1.40–4.32) and in-hospital mortality (RR = 1.70, 95% CI = [1.08–2.69]) compared to no PCI. Post-TAVI PCI was associated with higher 1-year mortality compared to other strategies. While no significant differences in major bleeding or stroke were observed, PCI during TAVI versus no PCI (RR = 3.63, 95% CI = 1.27–10.43) showed a higher rate of 30-day MI.

Conclusion

Our findings suggest that among patients with severe AS and CAD undergoing TAVI, PCI concomitantly with TAVI seems to be associated with worse 30-day outcomes compared with no PCI. PCI after TAVI demonstrated an increased risk of 1-year mortality compared to alternative strategies. Choosing a timing strategy should be individualized based on patient characteristics and procedural considerations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信